These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7836547)

  • 1. Optimal sampling theory: effect of error in a nominal parameter value on bias and precision of parameter estimation.
    Drusano GL; Forrest A; Yuen G; Plaisance K; Leslie J
    J Clin Pharmacol; 1994 Oct; 34(10):967-74. PubMed ID: 7836547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sampling schedule design for populations of patients.
    Tam VH; Preston SL; Drusano GL
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2888-91. PubMed ID: 12936990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of some practical sampling strategies for population pharmacokinetic studies.
    Jonsson EN; Wade JR; Karlsson MO
    J Pharmacokinet Biopharm; 1996 Apr; 24(2):245-63. PubMed ID: 8875349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive control of theophylline therapy: importance of blood sampling times.
    D'Argenio DZ; Khakmahd K
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):547-59. PubMed ID: 6668559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of population D-optimal designs via pharmacokinetic simulations.
    Hooker AC; Foracchia M; Dodds MG; Vicini P
    Ann Biomed Eng; 2003 Jan; 31(1):98-111. PubMed ID: 12572660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum a posteriori Bayesian estimation of epirubicin clearance by limited sampling.
    Ralph LD; Thomson AH; Dobbs NA; Twelves C
    Br J Clin Pharmacol; 2004 Jun; 57(6):764-72. PubMed ID: 15151522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patients.
    Drusano GL; Forrest A; Plaisance KI; Wade JC
    Clin Pharmacol Ther; 1989 Jun; 45(6):635-41. PubMed ID: 2659235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
    Sun H; Ette EI; Ludden TM
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
    Ette EI; Kelman AW; Howie CA; Whiting B
    Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.
    Peng B; Boddy AV; Cole M; Pearson AD; Chatelut E; Rubie H; Newell DR
    Eur J Cancer; 1995 Oct; 31A(11):1804-10. PubMed ID: 8541105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.
    Baille P; Bruno R; Schellens JH; Webster LK; Millward M; Verweij J; Montay G
    Clin Cancer Res; 1997 Sep; 3(9):1535-8. PubMed ID: 9815840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Inverse Probability Bootstrap Sampling to Eliminate Sample Induced Bias in Model Based Analysis of Unequal Probability Samples.
    Nahorniak M; Larsen DP; Volk C; Jordan CE
    PLoS One; 2015; 10(6):e0131765. PubMed ID: 26126211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal design of sampling schedules for studying glucose kinetics with tracers.
    Cobelli C; Ruggeri A
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E444-50. PubMed ID: 2782404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of optimal sampling strategy and adaptive study design.
    Drusano GL; Forrest A; Snyder MJ; Reed MD; Blumer JL
    Clin Pharmacol Ther; 1988 Aug; 44(2):232-8. PubMed ID: 3293877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of passive smoking on theophylline clearance.
    Matsunga SK; Plezia PM; Karol MD; Katz MD; Camilli AE; Benowitz NL
    Clin Pharmacol Ther; 1989 Oct; 46(4):399-407. PubMed ID: 2791443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.
    Nguyen L; Tranchand B; Puozzo C; Variol P
    Br J Clin Pharmacol; 2002 May; 53(5):459-68. PubMed ID: 11994051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.